Clinical Update in Heart Failure with Preserved Ejection Fraction

C Krittanawong, WM Britt, A Rizwan, R Siddiqui… - Current Heart Failure …, 2024 - Springer
Abstract Purpose of Review To review the most recent clinical trials and data regarding
epidemiology, pathophysiology, diagnosis, and treatment of heart failure with preserved …

State-of-the-art imaging of infiltrative cardiomyopathies: a scientific statement from the American Heart Association

A Kottam, K Hanneman, A Schenone… - Circulation …, 2023 - Am Heart Assoc
Infiltrative cardiomyopathies comprise a broad spectrum of inherited or acquired conditions
caused by deposition of abnormal substances within the myocardium. Increased wall …

[HTML][HTML] Cardiac amyloidosis

P Shams, I Ahmed - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Objectives: Describe infiltrative cardiomyopathy and the pathophysiology of cardiac
amyloidosis. Summarize clinical findings of cardiac amyloidosis, giving examples of different …

Quantitative SPECT/CT parameters in the assessment of transthyretin cardiac amyloidosis—a new dimension of molecular imaging

M Gherghe, AM Lazar, MC Sterea, PM Spiridon… - Journal of …, 2023 - mdpi.com
Aims: Cardiac transthyretin amyloidosis (ATTR) represents the accumulation of misfolded
transthyretin in the heart interstitium. Planar scintigraphy with bone-seeking tracers has long …

[HTML][HTML] From Molecular to Radionuclide and Pharmacological Aspects in Transthyretin Cardiac Amyloidosis

SM Stanciu, R Jurcut, R Dragoi Galrinho… - International Journal of …, 2024 - mdpi.com
Amyloidosis is a rare pathology characterized by protein deposits in various organs and
tissues. Cardiac amyloidosis (CA) can be caused by various protein deposits, but …

Advancements and challenges in cardiac amyloidosis imaging: A comprehensive review of novel techniques and clinical applications

A Albulushi, R Al Hajri, C Hovseth, Z Jawa… - Current Problems in …, 2024 - Elsevier
Cardiac amyloidosis, characterized by amyloid fibril deposition in the myocardium, leads to
restrictive cardiomyopathy and heart failure. This review explores recent advancements in …

New advanced imaging parameters and biomarkers—A step forward in the diagnosis and prognosis of TTR cardiomyopathy

RC Rimbas, A Balinisteanu, SL Magda… - Journal of Clinical …, 2022 - mdpi.com
Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative disorder characterized by
extracellular myocardial deposits of amyloid fibrils, with poor outcome, leading to heart …

Amyloidosis and considerations for the hand surgeon

CR Brown, JD Bergin, DN Deal - The Journal of Hand Surgery, 2024 - Elsevier
Amyloidosis can lead to cardiac, renal, and other multiorgan failure. New treatments have
become available that can prolong survival but rely on early diagnosis. Manifestations of …

[HTML][HTML] Cardiac amyloidosis: evolving pathogenesis, multimodal diagnostics, and principles of treatment

GD Medarametla, RS Kahlon, L Mahitha, S Shariff… - EXCLI …, 2023 - ncbi.nlm.nih.gov
Amyloidosis is a protein deposition disorder in which insoluble fibril structures accumulate in
the bodily tissues damaging the organ function. Cardiac amyloidosis is a severe but under …

[HTML][HTML] Cardiovascular Aging and Risk Assessment: How Multimodality Imaging Can Help

M Hrabak Paar, M Muršić, J Bremerich, T Heye - Diagnostics, 2024 - mdpi.com
Aging affects the cardiovascular system, and this process may be accelerated in individuals
with cardiovascular risk factors. The main vascular changes include arterial wall thickening …